CWIS NON-FLAIL Randomized Controlled Trial

A Multicenter, Randomized Controlled Trial of Surgical Stabilization of Rib Fractures in Patients with Severe, Non-flail Fracture Patterns

Fredric Pieracci, MD, MPH, FACS
Principal investigator:

Fredric M. Pieracci, MD, MPH, FACS

Hypothesis: SSRF, as compared to standardized non-operative management, improves pain control, pulmonary function, risk of complications, and quality of life among patients with severe, non-flail chest fracture patterns
The objective of this trial is to investigate the efficacy of surgical stabilization of rib fractures (SSRF), as compared to non-operative management, for hospitalized patients with non-flail, severe rib fractures.
The study will be conducted within expert, high volume centers that participate in the Chest Wall Injury Society (CWIS). 
Participating Satellite Sites:
Trial Statistics

Number of enrolled sites: 21

Number of sites with IRB approval: 7

Number of sites actively enrolling patients: 6

Number of subjects enrolled: 29/100

Acute Innovations